Cabozantinib enhances CAIX specific CAR-T cells against renal cancer by improving effector functions and augmenting tumor immune microenvironmentQihong Li, Shishuo Sun, Shuyu Li et al.|Biochemical and Biophysical Research Communications|2024Cited by 6